• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Arteris Inc.

    2/18/25 5:29:01 PM ET
    $AIP
    Semiconductors
    Technology
    Get the next $AIP alert in real time by email
    S-8 1 d904102ds8.htm S-8 S-8

    As filed with the Securities and Exchange Commission on February 18, 2025

    Registration No. 333-   

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM S-8

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    Arteris, Inc.

    (Exact name of Registrant as specified in its charter)

     

     

     

    Delaware   27-0117058

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification Number)

    900 E. Hamilton Ave., Suite 300

    Campbell, CA

      95008
    (Address of Principal Executive Offices)   (Zip Code)

     

     

    2021 Incentive Award Plan

    2021 Employee Stock Purchase Plan

    (Full Title of the Plan)

     

     

    K. Charles Janac

    Arteris, Inc.

    President and Chief Executive Officer

    900 E. Hamilton Ave., Suite 300

    Campbell, CA 95008

    (408) 470-7300

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

     

    Copies to:

    Phillip S. Stoup, Esq.

    Sarah K. Solum, Esq.

    Freshfields US LLP

    One Bush Street, 17th Floor

    San Francisco, CA 94104

    Telephone: (650) 618-9250

     

     

    Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☐    Accelerated filer   ☐
    Non-accelerated filer   ☒    Smaller reporting company   ☒
         Emerging growth company   ☒

    If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

    Proposed sale to take place as soon after the effective date of the

    registration statement as awards under the plans are exercised and/or vest.

     

     

     


    PART I

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

    The information called for in Part I of Form S-8 is not being filed with or included in this Form S-8 (by incorporation by reference or otherwise) in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    In this Registration Statement, Arteris, Inc. is sometimes referred to as “Registrant,” “we,” “us” or “our.”

    REGISTRATION OF ADDITIONAL SECURITIES

    PURSUANT TO GENERAL INSTRUCTION E OF FORM S-8

    This Registration Statement on Form S-8 is filed by the Registrant, relating to (a) 2,036,246 shares of its common stock, $0.001 par value (the “Common Stock”), issuable to eligible employees, directors and consultants of the Registrant under the Registrant’s 2021 Incentive Award Plan (the “2021 Plan”) and (b) 407,249 shares of Common Stock issuable to eligible employees of the Registrant under the Registrant’s 2021 Employee Stock Purchase Plan (the “ESPP”). Shares available for issuance under the 2021 Plan and the ESPP were previously registered on registration statements on Form S-8 filed with the SEC on November 1, 2021, Registration No. 333-260620, March 7, 2022, Registration No. 333-263352, March 1, 2023, Registration No. 333-270173, and February 20, 2024, Registration No. 333-277200 (the “Prior Registration Statements”). The Prior Registration Statements are currently effective. This Registration Statement relates to securities of the same class as those to which the Prior Registration Statements relate and is submitted in accordance with Section E of the General Instructions to Form S-8 regarding Registration of Additional Securities. Pursuant to Section E of the General Instructions to Form S-8, the contents of the Prior Registration Statements are incorporated herein by reference and made part of this Registration Statement, except as amended hereby.

    Item 3. Incorporation of Documents by Reference.

    The SEC allows us to incorporate by reference the information we file with them, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this Registration Statement, and later information filed with the SEC will update and supersede this information. We hereby incorporate by reference into this Registration Statement the following documents previously filed with the SEC:

     

      •  

    the contents of the Registrant’s earlier Registration Statements on Form S-8 relating to the 2021 Plan and ESPP, previously filed with the SEC on November 1, 2021 (File No. 333-260620), March 7, 2022 (File No. 333-263352), March 1, 2023 (File No. 333-270173) and February 20, 2024 (File No.  333-277200);

     

      •  

    the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 18, 2025;

     

      •  

    the information specifically incorporated by reference into the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2023 from our Definitive Proxy Statement on Schedule 14A, filed with the SEC on April 23, 2024; and

     

      •  

    the description of the Registrant’s Common Stock which is registered under Section 12 of the Exchange Act, in the Registrant’s Registration Statement on Form 8-A, filed on October 22, 2021, including any amendments or reports filed for the purposes of updating such description.

    All documents that the Registrant subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to the registration statement which indicates that all of the shares of Common Stock offered have been sold or which deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents, except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, that is not deemed filed under such provisions. For the purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.


    Under no circumstances will any information filed under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.

    Item 8. Exhibits.

     

    Exhibit

    Number

            Incorporated by Reference     
      

    Exhibit Description

      

    Form

      

    Date

      

    Number

      

    Filed

    Herewith

      4.1    Amended and Restated Certificate of Incorporation of Arteris, Inc.    8-K    10/29/21    3.1   
      4.2    Amended and Restated Bylaws of Arteris, Inc.    8-K    10/29/21    3.2   
      4.3    Specimen Stock Certificate evidencing the shares of common stock.    S-1/A    10/18/21    4.1   
      5.1    Opinion of Freshfields US LLP.             X
     23.1    Consent of Freshfields US LLP (included in Exhibit 5.1).             X
     23.2    Consent of Deloitte & Touche LLP, independent registered public accounting firm.             X
     24.1    Power of Attorney. Reference is made to the signature page to the Registration Statement.             X
     99.1#    2021 Incentive Award Plan.    S-8    10/29/21    99.2(a)   
     99.2#    Form of Stock Option Award Agreement under Arteris, Inc. 2021 Incentive Award Plan.    S-1/A    10/18/21    10.14   
     99.3#    Form of Restricted Stock Unit Award Agreement under Arteris, Inc. 2021 Incentive Award Plan    S-1/A    10/18/21    10.15   
     99.4#    2021 Employee Stock Purchase Plan    S-8    10/29/21    99.3   
    107.1    Filing Fee Table             X

     

    #

    Indicates management contract or compensatory plan.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Campbell, State of California, on this 18th day of February, 2025.

     

    Arteris, Inc.
    By:  

    /s/ K. Charles Janac

      K. Charles Janac
      President and Chief Executive Officer

    POWER OF ATTORNEY

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Charles Janac and Nicholas B. Hawkins, and each of them, with full power of substitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file this Registration Statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

     

    Signature

      

    Title

      

    Date

    /s/ K. Charles Janac

    K. Charles Janac

       President and Chief Executive Officer (Principal Executive Officer) and Chairman of the Board of Directors    February 18, 2025

    /s/ Nicholas B. Hawkins

    Nicholas B. Hawkins

       Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)    February 18, 2025

    /s/ Wayne C. Cantwell

    Wayne C. Cantwell

       Director    February 18, 2025

    /s/ Raman K. Chitkara

    Raman K. Chitkara

       Director    February 18, 2025

    /s/ Isabelle F. Geday

    Isabelle F. Geday

       Director    February 18, 2025

    /s/ Claudia Fan Munce

    Claudia Fan Munce

       Director    February 18, 2025

    /s/ Joachim Kunkel

       Director    February 18, 2025
    Joachim Kunkel      

    /s/ S. Atiq Raza

    S. Atiq Raza

       Director    February 18, 2025

    /s/ Antonio J. Viana

    Antonio J. Viana

       Director    February 18, 2025
    Get the next $AIP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AIP

    DatePrice TargetRatingAnalyst
    9/1/2023$11.00 → $12.00Outperform
    TD Cowen
    3/4/2022$32.00 → $23.00Outperform
    Cowen
    11/22/2021$27.00Outperform
    Northland Capital
    11/22/2021$24.00Market Perform
    BMO Capital Markets
    11/22/2021$30.00Outperform
    Cowen
    11/22/2021$33.00Buy
    Jefferies
    11/22/2021$35.00Buy
    Rosenblatt
    More analyst ratings

    $AIP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on Arteris with a new price target

      TD Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $12.00 from $11.00 previously

      9/1/23 7:31:29 AM ET
      $AIP
      Semiconductors
      Technology
    • Cowen reiterated coverage on Arteris with a new price target

      Cowen reiterated coverage of Arteris with a rating of Outperform and set a new price target of $23.00 from $32.00 previously

      3/4/22 7:21:31 AM ET
      $AIP
      Semiconductors
      Technology
    • Northland Capital initiated coverage on Arteris with a new price target

      Northland Capital initiated coverage of Arteris with a rating of Outperform and set a new price target of $27.00

      11/22/21 8:59:18 AM ET
      $AIP
      Semiconductors
      Technology

    $AIP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Arteris Wins "AI Engineering Innovation Award" at the 2025 AI Breakthrough Awards

      CAMPBELL, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- In a market fueled by the compute demands of AI, Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating system-on-chip (SoC) creation, today announced that it has won the "AI Engineering Innovation Award" at the 8th annual AI Breakthrough Awards conducted by the market intelligence organization AI Breakthrough. Arteris was recognized for this year's launch of FlexGen, a revolutionary, smart network-on-chip (NoC) interconnect IP technology. Network-on-Chip (NoC) design for AI-centric semiconductors, particularly those targeting data center and automotive self-driving applications, presents significant complexity and

      6/26/25 9:00:00 AM ET
      $AIP
      Semiconductors
      Technology
    • Arteris Addresses Silicon Design Reuse Challenge with New Magillem Packaging Product for IP Blocks and Chiplets

      CAMPBELL, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced the immediate availability of Magillem Packaging, a new software product designed to simplify and speed up the process of building advanced chips used in everything from AI data centers to edge devices. As chip design becomes increasingly complex with more components, higher performance demands and tighter timelines, Magillem Packaging helps engineering teams work faster and more efficiently by automating one of the most time-consuming parts of the design process: assembling and reusing existing technology. "The soaring c

      6/23/25 9:00:00 AM ET
      $AIP
      Semiconductors
      Technology
    • Arteris Accelerates AI-Driven Silicon Innovation with Expanded Multi-Die Solution

      CAMPBELL, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- In a market reshaped by the compute demands of AI, Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP for accelerating semiconductor creation, today announced an expansion of its multi-die solution, delivering a foundational technology for rapid chiplet-based innovation. "In the chiplet era, the need for computational power increasingly exceeds what is available by traditional monolithic die designs," said K. Charles Janac, president and CEO of Arteris. "Arteris is leading the transition into the chiplet era with standards-based, automated and silicon-proven solutions that enable seamless integration across IP cores, chiplets, a

      6/17/25 9:00:00 AM ET
      $AIP
      Semiconductors
      Technology

    $AIP
    SEC Filings

    See more
    • SEC Form 144 filed by Arteris Inc.

      144 - Arteris, Inc. (0001667011) (Subject)

      7/3/25 1:29:40 PM ET
      $AIP
      Semiconductors
      Technology
    • SEC Form 144 filed by Arteris Inc.

      144 - Arteris, Inc. (0001667011) (Subject)

      7/1/25 4:34:28 PM ET
      $AIP
      Semiconductors
      Technology
    • SEC Form 144 filed by Arteris Inc.

      144 - Arteris, Inc. (0001667011) (Subject)

      7/1/25 4:34:06 PM ET
      $AIP
      Semiconductors
      Technology

    $AIP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Moll Laurent R sold $2,672 worth of shares (294 units at $9.09), decreasing direct ownership by 0.06% to 483,465 units (SEC Form 4)

      4 - Arteris, Inc. (0001667011) (Issuer)

      7/2/25 8:02:05 PM ET
      $AIP
      Semiconductors
      Technology
    • Director Raza Saiyed Atiq sold $198,492 worth of shares (19,809 units at $10.02) (SEC Form 4)

      4 - Arteris, Inc. (0001667011) (Issuer)

      7/1/25 8:07:07 PM ET
      $AIP
      Semiconductors
      Technology
    • President and CEO Janac K Charles sold $210,824 worth of shares (21,286 units at $9.90), decreasing direct ownership by 0.87% to 302,998 units (SEC Form 4)

      4 - Arteris, Inc. (0001667011) (Issuer)

      7/1/25 8:06:39 PM ET
      $AIP
      Semiconductors
      Technology

    $AIP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Arteris Inc.

      SC 13G/A - Arteris, Inc. (0001667011) (Subject)

      11/13/24 4:32:26 PM ET
      $AIP
      Semiconductors
      Technology
    • SEC Form SC 13G filed by Arteris Inc.

      SC 13G - Arteris, Inc. (0001667011) (Subject)

      6/27/24 3:46:24 PM ET
      $AIP
      Semiconductors
      Technology
    • SEC Form SC 13G/A filed by Arteris Inc. (Amendment)

      SC 13G/A - Arteris, Inc. (0001667011) (Subject)

      1/24/24 4:05:55 PM ET
      $AIP
      Semiconductors
      Technology

    $AIP
    Leadership Updates

    Live Leadership Updates

    See more
    • Joachim Kunkel Joins Arteris Board of Directors

      CAMPBELL, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that Joachim Kunkel will join its Board of Directors. Mr. Kunkel most recently served as the General Manager of the Intellectual Property (IP) business unit at Synopsys where he grew Synopsys' IP revenue to over $1.5 billion, making Synopsys the second largest semiconductor IP company in the world. With three decades of experience at Synopsys, Mr. Kunkel brings a wealth of knowledge and leadership to Arteris. Prior to joining Synopsys, Joachim Kunkel co-founded and served as managing director of CADIS GmbH, where

      9/16/24 5:00:00 PM ET
      $AIP
      Semiconductors
      Technology

    $AIP
    Financials

    Live finance-specific insights

    See more
    • Arteris Announces Financial Results for the First Quarter and Estimated Second Quarter and Updated Full Year 2025 Guidance

      CAMPBELL, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the first quarter ended March 31, 2025 and provided estimated second quarter and updated full year 2025 guidance. "In the first quarter, we delivered record annual contract value plus royalties of $66.8 million and generated $2.7 million in positive free cash flow, driven by sustained demand for commercial semiconductor System IP products across enterprise computing, communications, and automotive semiconductors," said K. Charles Janac, President and CEO of Arteris. "Looking beyond the near-ter

      5/13/25 4:05:00 PM ET
      $AIP
      Semiconductors
      Technology
    • Arteris to Announce Financial Results for the First Quarter 2025 on Tuesday, May 13, 2025

      CAMPBELL, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced it will release its financial results for the first quarter ended March 31, 2025, after market close on Tuesday, May 13, 2025. Management will host a conference call on Tuesday, May 13, 2025, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing:  United States/Canada Toll Free: +1-800-717-1738 International Toll: +1-646-307-1865     Please join the call 5-10 minutes prior to the scheduled start time to avoid a delay in connecting. A live webcast will be ava

      4/24/25 8:39:18 AM ET
      $AIP
      Semiconductors
      Technology
    • Arteris Announces Financial Results for the Fourth Quarter and Full Year 2024 and Estimated First Quarter and Full Year 2025 Guidance

      CAMPBELL, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (NASDAQ:AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced financial results for the fourth quarter and year ended December 31, 2024 and provided first quarter and full year 2025 guidance. "In the fourth quarter of 2024, we achieved a record Annual Contract Value plus royalties of $65.1 million, driven by strong demand for our commercial semiconductor System IP products, particularly in AI-driven enterprise computing and automotive SoCs," said K. Charles Janac, President and CEO of Arteris. "As AI adoption accelerates across data centers, autonomous driving, and edge devic

      2/18/25 4:05:09 PM ET
      $AIP
      Semiconductors
      Technology